You are here

Home

Biblio

Journal Article
Jiang S, Wen N, Li Z, Dube U, Del Aguila J, Budde J, Martinez R, Hsu S, Fernández MV, Cairns NJ et al..  2018.  Integrative system biology analyses of CRISPR-edited iPSC-derived neurons and human brains reveal deficiencies of presynaptic signaling in FTLD and PSP.. Transl Psychiatry. 8(1):265.
Zhou Z, Wang W, San Wang L-, Zhang NRuonan.  2018.  Integrative DNA copy number detection and genotyping from sequencing and array-based platforms.. Bioinformatics. 34(14):2349-2355.
Panitch R, Hu J, Chung J, Zhu C, Meng G, Xia W, Bennett DA, Lunetta KL, Ikezu T, Au R et al..  2021.  Integrative brain transcriptome analysis links complement component 4 and HSPA2 to the APOE ε2 protective effect in Alzheimer disease.. Mol Psychiatry. 26(10):6054-6064.
Novikova G, Kapoor M, Tcw J, Abud EM, Efthymiou AG, Chen SX, Cheng H, Fullard JF, Bendl J, Liu Y et al..  2021.  Integration of Alzheimer's disease genetics and myeloid genomics identifies disease risk regulatory elements and genes.. Nat Commun. 12(1):1610.
Wingo AP, Liu Y, Gerasimov ES, Gockley J, Logsdon BA, Duong DM, Dammer EB, Robins C, Beach TG, Reiman EM et al..  2021.  Integrating human brain proteomes with genome-wide association data implicates new proteins in Alzheimer's disease pathogenesis.. Nat Genet. 53(2):143-146.
Devanand DP, Lee S, Luchsinger JA, Andrews H, Goldberg T, Huey ED, Schupf N, Manly J, Stern Y, Kreisl WC et al..  2020.  Intact global cognitive and olfactory ability predicts lack of transition to dementia.. Alzheimers Dement. 16(2):326-334.
Weitzman SA, Narasimhan S, He Z, Changolkar L, McBride JD, Zhang B, Schellenberg GD, Trojanowski JQ, M Y Lee V.  2020.  Insoluble Tau From Human FTDP-17 Cases Exhibit Unique Transmission Properties In Vivo.. J Neuropathol Exp Neurol. 79(9):941-949.
Ayata P, Schaefer A.  2020.  Innate sensing of mechanical properties of brain tissue by microglia.. Curr Opin Immunol. 62:123-130.
Amlie-Wolf A, Tang M, Mlynarski EE, Kuksa PP, Valladares O, Katanić Ž, Tsuang D, Brown CD, Schellenberg GD, San Wang L-.  2018.  INFERNO: inferring the molecular mechanisms of noncoding genetic variants.. Nucleic Acids Res. 46(17):8740-8753.
Griswold AJ, Celis K, Bussies PL, Rajabli F, Whitehead PL, Hamilton-Nelson KL, Beecham GW, Dykxhoorn DM, Nuytemans K, Wang L et al..  2021.  Increased APOE ε4 expression is associated with the difference in Alzheimer's disease risk from diverse ancestral backgrounds.. Alzheimers Dement. 17(7):1179-1188.
Xu H, O'Reilly M, Gibbons GS, Changolkar L, McBride JD, Riddle DM, Zhang B, Stieber A, Nirschl J, Kim S-J et al..  2021.  In vitro amplification of pathogenic tau conserves disease-specific bioactive characteristics.. Acta Neuropathol. 141(2):193-215.
Wolters FJ, Yang Q, Biggs ML, Jakobsdottir J, Li S, Evans DS, Bis JC, Harris TB, Vasan RS, Zilhao NR et al..  2019.  The impact of APOE genotype on survival: Results of 38,537 participants from six population-based cohorts (E2-CHARGE).. PLoS One. 14(7):e0219668.
Griswold AJ, Sivasankaran SK, Van Booven D, Gardner OK, Rajabli F, Whitehead PL, Hamilton-Nelson KL, Adams LD, Scott AM, Hofmann NK et al..  2020.  Immune and Inflammatory Pathways Implicated by Whole Blood Transcriptomic Analysis in a Diverse Ancestry Alzheimer's Disease Cohort.. J Alzheimers Dis. 76(3):1047-1060.
Baird DA, Liu JZ, Zheng J, Sieberts SK, Perumal T, Elsworth B, Richardson TG, Chen C-Y, Carrasquillo MM, Allen M et al..  2021.  Identifying drug targets for neurological and psychiatric disease via genetics and the brain transcriptome.. PLoS Genet. 17(1):e1009224.
He Z, Liu L, Wang C, Le Guen Y, Lee J, Gogarten S, Lu F, Montgomery S, Tang H, Silverman EK et al..  2021.  Identification of putative causal loci in whole-genome sequencing data via knockoff statistics.. Nat Commun. 12(1):3152.
Lo M-T, Kauppi K, Fan C-C, Sanyal N, Reas ET, Sundar VS, Lee W-C, Desikan RS, McEvoy LK, Chen C-H.  2019.  Identification of genetic heterogeneity of Alzheimer's disease across age.. Neurobiol Aging. 84:243.e1-243.e9.
Farron MR, Kabeto MU, Dey ABallav, Banerjee J, Levine DA, Langa KM.  2020.  Hypertension and Cognitive Health Among Older Adults in India.. J Am Geriatr Soc. 68 Suppl 3:S29-S35.
Kuksa PP, Li F, Kannan S, Gregory BD, Leung YYee, San Wang L-.  2020.  HiPR: High-throughput probabilistic RNA structure inference.. Comput Struct Biotechnol J. 18:1539-1547.
Kuksa PP, Amlie-Wolf A, Hwang Y-C, Valladares O, Gregory BD, San Wang L-.  2020.  HIPPIE2: a method for fine-scale identification of physically interacting chromatin regions.. NAR Genom Bioinform. 2(2):lqaa022.
Ewers M, Biechele G, Suárez-Calvet M, Sacher C, Blume T, Morenas-Rodriguez E, Deming Y, Piccio L, Cruchaga C, Kleinberger G et al..  2020.  Higher CSF sTREM2 and microglia activation are associated with slower rates of beta-amyloid accumulation.. EMBO Mol Med. 12(9):e12308.
Wu HMan, Goate AM, O'Reilly PF.  2021.  Heterogeneous effects of genetic risk for Alzheimer's disease on the phenome.. Transl Psychiatry. 11(1):406.
Smith EE, Biessels GJan, De Guio F, de Leeuw FErik, Duchesne S, Düring M, Frayne R, M Ikram A, Jouvent E, MacIntosh BJ et al..  2019.  Harmonizing brain magnetic resonance imaging methods for vascular contributions to neurodegeneration.. Alzheimers Dement (Amst). 11:191-204.
Wheeler NR, Benchek P, Kunkle BW, Hamilton-Nelson KL, Warfe M, Fondran JR, Haines JL, Bush WS.  2020.  Hadoop and PySpark for reproducibility and scalability of genomic sequencing studies.. Pac Symp Biocomput. 25:523-534.
Marioni RE, Harris SE, Zhang Q, McRae AF, Hagenaars SP, W Hill D, Davies G, Ritchie CW, Gale CR, Starr JM et al..  2018.  GWAS on family history of Alzheimer's disease.. Transl Psychiatry. 8(1):99.
Fulton-Howard B, Goate AM, Adelson RP, Koppel J, Gordon ML, Barzilai N, Atzmon G, Davies P, Freudenberg-Hua Y.  2021.  Greater effect of polygenic risk score for Alzheimer's disease among younger cases who are apolipoprotein E-ε4 carriers.. Neurobiol Aging. 99:101.e1-101.e9.

Pages

Theme by Danetsoft and Danang Probo Sayekti inspired by Maksimer